Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis
Impact Factor: 4.9 (2023). 5-Year Impact Factor: 5.5 (2023). Se publicó como preprint en: https://www.preprints.org/manuscript/202402.0587/v1
Main Authors: | Magi, María S., de Lafuente, Yanina, Quarta, Eride, Palena, María C., Ardiles, Perla del R., Páez, Paulina L., Sonvico, Fabio, Buttini, Francesca, Jimenez Kairuz, Alvaro F. |
---|---|
Other Authors: | https://orcid.org/0009-0007-8482-4144 |
Format: | info:eu-repo/semantics/publishedVersion |
Language: | eng |
Published: |
Academic Editor: Vivek Verma
2024
|
Subjects: | |
Online Access: | http://hdl.handle.net/11086/552768 https://www.mdpi.com/1999-4923/16/4/436 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054002/ |
Similar Items
-
Thermodynamic and rheological properties of polyelectrolyte systems
by: Jimenez Kairuz, Alvaro Federico, et al.
Published: (2022) -
High concentrations of sodium chloride improve microbicidal activity of ibuprofen against common cystic fibrosis pathogens
by: Muñoz, Adrián, et al.
Published: (2023) -
Thyroglossal duct cyst, does it influence its symptoms in the oral cavity?
by: Caciva, Ricardo Crhistian, et al.
Published: (2022) -
Magnetic hybrid nanomaterial based on a natural polymer and an amino acid as pH/temperature dual-responsive nanoplatform for the delivery of tamoxifen
by: Torres, Jazmín, et al.
Published: (2024) -
Neumonología /
Published: (1992)